Search Results
1 - STEMCELL Technologies Inc. to Host Stem Cell Training Courses
VANCOUVER-(Business Wire)-September 2, 2009 - STEMCELL Technologies has announced the schedule for their fall training program. This includes 2-day courses on mesenchymal stem cell biology (October 2nd and 3rd), mammary stem cell biology (October 17th and 18th), neural stem cell biology (October...
2 - Harleigh Willmott Joins Meniscus Limited as Medical Director
WEST CONSHOHOCKEN, Pa.-(Business Wire)-February 9, 2009 - Meniscus Limited proudly announces the hiring of Harleigh Willmott, PhD, as Medical Director. With a 12-year tenure developing and implementing pharmaceutical initiatives and a PhD in biology, Harleigh brings a wealth of strategic...
3 - Research and Markets: Protein Targeting with Small Molecules: Chemical Biology Techniques and Applications
DUBLIN-(Business Wire)-September 16, 2009 - Research and Markets . Index. For more information visit http://www.researchandmarkets.com/research/282d33/protein_targeting
4 - CODA Genomics Signs Collaboration Agreement with Genencor
LAGUNA HILLS, Calif.-(Business Wire)-October 14, 2008 - CODA Genomics, a synthetic biology company focused on the bioindustrial and life sciences industries, today announced signed a collaboration agreement with Genencor, a division of Danisco A/S, a leading industrial biotechnology company that...
5 - National Cancer Institute Selects CambridgeSoft to Support Chemical Biology Consortium
CAMBRIDGE, Mass.-(Business Wire)-September 29, 2008 - The National Cancer Institute has selected the ChemBioOffice Enterprise suite as the single solution Informatics platform to support a highly collaborative drug discovery partnership, the Chemical Biology Consortium. The ChemBioOffice...
6 - Minnow Medical to Present at Rodman & Renshaw Healthcare Conference on September 10
SAN DIEGO-(Business Wire)-September 1, 2009 - Minnow Medical, Inc., a developer of innovative products to treat artery disease, today announced that President and Chief Executive Officer Tom Steinke is scheduled to make an investor presentation at the Rodman & Renshaw Healthcare Conference on...
7 - Calvin B. Harley to Retire as Chief Scientific Officer of Geron
MENLO PARK, Calif.-(Business Wire)-September 8, 2009 - Geron Corporation (Nasdaq:GERN) today announced that Calvin B. Harley, Ph.D., the company’s chief scientific officer (CSO) for telomerase technologies, will retire on September 15, 2009. Dr. Harley joined Geron in 1993 and served as CSO...
8 - Research and Markets: This Global Research Report in Medicine and Biology Nanoscience and Nanotechnology is Now Available
DUBLIN, Ireland-(Business Wire)-November 19, 2008 - Research and Markets . - Nanomaterials, nanophotonics, nanoelectronics and nanoscience in medicine & biology represent the largest concentration of R&D. - Growth is particularly fast in emerging domains, namely NEMS, energy and environment...
9 - Nature’s Biology Announces Transparent “Free-Trial Offer” for its New Product Ultra Prime Amidst Acai Marketing Scams
WOODLAND HILLS, Calif.-(Business Wire)-January 29, 2009 - Nature’s Biology is introducing an honest and transparent free-trial offer for a doctor-formulated energy boosting, weight loss and antioxidant supplement which contains Acai, among other high-quality ingredients. Consumers interested in...
10 - Research and Markets: Immunology: Understanding The Immune System, 2nd Edition
DUBLIN-(Business Wire)-September 22, 2009 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Immunology: Understanding The Immune System, 2nd Edition" to their offering. Immunology: Understanding the Immune System, Second Edition, is a comprehensive and...
11 - OVP Venture Partners Set to Expand Efforts in Digital Biology in 2009
SEATTLE-(Business Wire)-December 6, 2008 - Early-stage venture capital firm OVP Venture Partners (OVP) announced today that venture partner Carl Weissman will expand his role at the firm, becoming a Managing Director in 2009. Mr. Weissman joined the firm in February of 2007 to focus on investments...
12 - PerkinElmer and the European Molecular Biology Laboratory (EMBL) Announce Corporate Partnership to Support EMBL Advanced Training Centre
WALTHAM, Mass.-(Business Wire)-November 24, 2008 - PerkinElmer, Inc., a global leader in life science research, drug discovery and cellular science, and the European Molecular Biology Laboratory (EMBL) today announced that they have entered into a corporate partnership in support of the EMBL’s...
13 - miRagen Therapeutics Chief Scientific Advisor wins the American Heart Association National Research Achievement Award
BOULDER, Colo.-(Business Wire)-November 13, 2008 - miRagen Therapeutics, Inc., a biopharmaceutical company focused on the discovery and development of breakthrough therapies for cardiovascular and muscle disease based on microRNA biology, today announced that its Chief Scientific Advisor and...
14 - David Bearss Resigns as Chief Scientific Officer to Join Huntsman Cancer Institute as Co-director of Center for Investigational Therapeutics
DUBLIN, Calif.-(Business Wire)-September 21, 2009 - SuperGen Inc. (Nasdaq:SUPG) announced that, effective October 16, 2009, David Bearss, Ph.D., will resign as SuperGen’s Chief Scientific Officer, and be engaged as a long-term biology consultant to the Company. In addition, Dr. Bearss will...
15 - Research and Markets: The Year in Ecology and Conservation Biology, 2009 - in-Depth Reviews of the Major Issues and Emerging Topics in Ecology and Conservation Biology
DUBLIN-(Business Wire)-September 11, 2009 - Research and Markets . Index of Contributors. For more information visit http://www.researchandmarkets.com/research/19909b/the_year_in_ecolog
16 - TRADE NEWS: Agilent Technologies, Shanghai Institute of Biological Sciences and Chinese Academy of Sciences Open Center for Systems Biology
SANTA CLARA, Calif. & SHANGHAI-(Business Wire)-September 24, 2009 - Agilent Technologies Inc. (NYSE:A) today announced the opening of the Shanghai Institute of Biological Sciences (SIBS)-Agilent Center for Systems Biology in Shanghai, China. The center will feature multiple technology...
17 - European Molecular Biology Laboratory (EMBL) Signs Agreement to License Themis and Surflex-Dock Technologies from Tripos
ST. LOUIS, Mo.-(Business Wire)-February 17, 2009 - Tripos™, a leading provider of drug discovery informatics products and services, today announced an agreement with the European Molecular Biology Laboratory (EMBL), Europe’s leading research institution for molecular biology, to license...
18 - Dr. Vicki L. Chandler Named Chief Program Officer, Science at Gordon and Betty Moore Foundation
SAN FRANCISCO-(Business Wire)-December 29, 2008 - The Gordon and Betty Moore Foundation today announced the appointment of Dr. Vicki L. Chandler as Chief Program Officer for the Foundation’s Science Program, effective February 17, 2008. Chandler will develop and manage the Foundation’s...
19 - Genentech Announces Vice President Appointment in Research
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-January 21, 2009 - Genentech, Inc. (NYSE:DNA) today announced the appointment of Jennifer A. Doudna, Ph.D., to Vice President, Discovery Research. In this newly created position, Doudna will oversee the departments of protein chemistry and structural...
20 - VistaGen Receives Significant Stem Cell Tools and Technologies Grant from California Institute for Regenerative Medicine
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-December 16, 2008 - VistaGen Therapeutics announced today that the California Institute for Regenerative Medicine (CIRM), the State’s stem cell agency, has awarded a major grant to the Company to expand ongoing development and commercialization of its...
